2310033P09Riktm1(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
2310033P09Riktm1(KOMP)Wtsi |
Name: |
RIKEN cDNA 2310033P09 gene; targeted mutation 1, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4841082 |
Gene: |
2310033P09Rik Location: Chr11:59099187-59101562 bp, + strand Genetic Position: Chr11, 37.05 cM, cytoband B2
|
IMPC: |
2310033P09Rik gene page |
|
Mutant Cell Lines: |
EPD0673_1_A10, EPD0673_1_A12, EPD0673_1_B09, EPD0673_1_B12, EPD0673_1_C09, EPD0673_1_C12, EPD0673_1_D10, EPD0673_1_D11, EPD0673_1_E09, EPD0673_1_E10, EPD0673_1_E11, EPD0673_1_E12, EPD0673_1_F12, EPD0673_1_H12 |
Germline Transmission: |
Unknown
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The insertion of the L1L2_Bact_P cassette created a deletion of size 1614 starting at position 59099626 and ending at position 59101240 of Chromosome 11 (Genome Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site.
(J:148605, J:173534)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 1 line available
|
Carrying any 2310033P09Rik Mutation: |
7 strains or lines available
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
2 reference(s) |
|